Who we are

The management team of NEO New Oncology


Corey R. Bouwman

Chief Executive Officer

Since autumn 2017, Corey R. Bouwman is the Chief Executive Officer at NEO New Oncology. Previously, he was responsible for Marketing, Sales, Healthcare Account Management and Strategic Market Development in the area Respiratory, Inflammation and Autoimmunity at the leading pharmaceutical company AstraZeneca as Vice President and member of the executive management. In 2009–2015, Corey held various executive management positions in Marketing, Sales, and business strategy of the pharmaceutical company Chiesi Group.

Christian Robrecht

Chief Financial Officer

Together with Corey R. Bouwman, Christian Robrecht sits on the executive board of NEO New Oncology GmbH. Christian Robrecht has been with Siemens AG since 1992. After completing his degree in business management, Christian Robrecht was employed in various business units of the company and has been working in the Healthcare division since 2004. Since 2008, he is responsible for the sales and service business of the »West« region for Siemens Healthineers as a commercial manager in the German organization.

Dr. Johannes Heuckmann

Chief Scientific Officer

Johannes Heuckmann is your contact person for all scientific and technical questions on molecular genetic testing, data processing and data analysis. He is a biomedic who specializes in the field of functional cancer genomics. Johannes Heuckmann is the co-author of numerous international research papers and has been instrumental in developing our diagnostic NEO technology.


Dr. Lukas C. Heukamp (MB PhD)

Head of Medical Office

Lukas C. Heukamp is your contact person for all questions pertaining to diagnostics and interpretation of molecular genetic test results. He is a board certified pathologist as well as a trained molecular biologist. The focus of his long-standing research is the genomic stratification of patients for novel targeted therapeutic approaches. In his capacity as joint study director of the Lung Cancer Group Cologne, Lukas C. Heukamp was involved in the routine molecular pathological diagnosis of more than 3,000 cancer patients per year. He is the author of numerous peer-reviewed publications on targeted cancer therapies and molecular diagnostics.

Dr. Jutta Fritz, MBA

Head of Business Development

Jutta Fritz is your contact person pertaining to all questions regarding cooperation. She is a molecular biologist and for a number of years was responsible for the business development of the biotechnology company Kinaxo. Subsequently, she became Vice President of Business Development at Evotec AG, leading the proteomics division, which sought to elucidate the mode of action of oncological drugs. Jutta Fritz was responsible for numerous collaborations in the field of drug testing.

Dr. Sebastian Bartel

Head of Quality Management

Sebastian Bartel is the Head of Quality Management and Regulatory Affairs at NEO New Oncology. From 2013, Sebastian Bartel held a position as Quality Consultant at Siemens, supporting all Siemens Healthcare Business Units in questions regarding Quality Management and Auditing. Sebastian holds a PhD in Analytical Chemistry and has several years of experience in Bioanalytics and Medical Device Development in different companies. 


Thomas Franz

Head of IT

Thomas Franz leads the Information Technology Department and is your contact for IT-related inquiries. With more than 20 years of expertise in heterogeneous IT environments, he has been instrumental in setting up the IT systems and processes in the company.

Dr. Christian Glöckner

Head of Research

Christian Glöckner is responsible for establishing and implementing new technologies at New Oncology. Upon completion of his doctorate on the function of DNA polymerases, he carried out research on precursor molecules for new drugs at The Scripps Research Institute, CA, USA. He then worked for many years as a scientist at Illumina, the world market leader in the field of next generation sequencing.

Sotirios Lakis MD, MSc

Head of Molecular Pathology

Sotirios Lakis is NEO New Oncology´s in-house pathologist. He is board certified with years´ experience in molecular diagnostic methods and he holds a master´s degree in Complex Systems and Networks from the Aristotle University of Thessaloniki. His doctorate project focuses on the impact of heterogeneity on ovarian cancer outcomes. As a cancer translational scientist, he has studied the clinical validity of multiple protein and genomic markers in breast, colorectal and lung cancers and he has co-authored numerous peer-reviewed publications.    


Dr. Erika Mariotti

Head of Development

Erika Mariotti leads the Development Department consisting of highly specialized and experienced computational biologists, bioinformaticians, software developers and is responsible for the implementation of new analysis bioinformatic tools at NEO New Oncology. She joined the company in 2014 and was involved in setting up the routine bioinformatics data processing. Erika holds a PhD in biomedical engineering.

Dr. Roopika Menon

Head of Sample Operations & Analysis

Roopika Menon leads the Sample Operations & Analysis Department and is your contact for queries related to sample logistics, processing, and data analysis. She received her doctorate in the field of Molecular Biomedicine with a specialization in prostate cancer. With a strong publication record to her credit, she has been actively involved in setting up the diagnostic routines as well as overseeing and maintaining the day to day technical operations in the company.


Kontakt

Telephone

Office: +49.221.888.23 80

Address

NEO New Oncology GmbH
Gottfried-Hagen-Str. 20
51105 Cologne
Germany

ImprintPrivacy policy

Newoncology.com uses cookies to make the website more user-friendly. By continuing to use the website, you agree to the use of cookies. If you do not agree to the storage of cookies, you will find further information HERE.

ok